Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan

Human Mutation

Volumn 8, Issue 4, 1996, Pages 348-357

  Zbar, Berton ^b   Kishida, Takeshi ^b   Chen, Fan ^a   Schmidt, Laura ^a   Maher, Eamonn R ^c   Richards, Frances M ^m   Crossey, Paul A ^c   Webster, Andrew R ^c   Affara, Nabeel A ^c   Ferguson Smith, Malcolm A ^c   Brauch, Hiltrud ^j   Glavac, Damjan ^l   Neumann, Hartmut P H ⁱ   Tisherman, Sam ^d   Mulvihill, John J ^d   Gross, David J ^k   Shuin, Taro ^f   Whaley, Jean ^e   Seizinger, Berndt ^e   Kley, Nickolai ^e   Olschwang, Sylviane ^g   Boisson, Cecile ^g   Richard, Stephane ^g   Lips, C H M ^h   Marston Linchan, W ^b   Lerman, Michael ^b   more..

^a SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f YOKOHAMA CITY UNIVERSITY   (Japan)

^g CENTRE HOSPITALIER SAINTE ANNE   (France)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^l UNIVERSITY OF LJUBLJANA   (Slovenia)

^m NONE

more..

Author keywords

Germline mutations; Pheochromocytoma; Renal cell carcinoma; Von Hippel Lindau disease

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CAUCASIAN; DISEASE ASSOCIATION; EUROPE; GENE MUTATION; HUMAN; JAPAN; KIDNEY CARCINOMA; NORTH AMERICA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROGNOSIS; VON HIPPEL LINDAU DISEASE;

ADRENAL GLAND NEOPLASMS; ASIAN CONTINENTAL ANCESTRY GROUP; ETHNIC GROUPS; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; GENES, TUMOR SUPPRESSOR; GENOTYPE; HIPPEL-LINDAU DISEASE; HUMANS; INTRONS; ISRAEL; JAPAN; KIDNEY NEOPLASMS; LIGASES; MUTATION; NORTH AMERICA; PHENOTYPE; PHEOCHROMOCYTOMA; POINT MUTATION; PROTEINS; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 16144365122     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3     Document Type: Article

References (43)

1. Aso T, Lane WE, Conaway JW, Conaway RC (1995) Elongin (SIII): A multisubunit regulator of elongation by RNA polymerase II. Science 269:1439-1443.
2. Beaudet AL, Tsui L-C. (1993) A suggested nomenclature for designating mutations. Hum Mutat 2:245-248.
3. Brauch H, Kishida T, Glavac D, Chen F, Pausch F, Hofler H, Latif F, Lerman MI, Zbar B, Neumann HPH (1995) von Hippel-Lindau (VHL) disease in the Black Forest region of Germany: Evidence for a founder effect. Hum Genet 95:551-556.
4. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR. Orcutt ML, Duh FM, Glenn G, Green J, Hsia YE, Lamiell J, Li H, Wei MH, Schmidt I, Tory K, Kuzmin I, Stackhouse T, Latif F, Linehan WM, Lerman MI, Zbar B. (1995) Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlation with disease phenorype. Hum Mutat 5:66-75.
5. Clinical Research Group for VHL in Japan (1995) Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Hum Mol Genet 4:2233-2237.
6. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara NA, Ferguson-Smith MA, Maher E (1994) Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotypes. Hum Mol Genet 3:1301-1308.
7. Dietrich WF, Lander ES, Smith JS, Moser AR, Could KA, Borenstein N, Dove W (1993) Genetic identification of Morn-1, a major modifier locus affected Min-induced intestinal neoplasia. Cell 75:635-639.
8. Duan DR, Pause A, Burgess WH, Aso T, Chen DYT, Garrett KP, Conaway RC, Conaway JW, Linehan WM, Klausner RD (1955) Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:1402-1406.
9. Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MMF, a Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, Buys CHCM, Maher E (1994) Somatic mutations of the von Hippel-Lindau disease tumor suppressor gene in non-familial clear cell renal carcinoma. Human Mol Genet 3:2169-2173.
10. Gilcrease MS, Schmidt L, Zbar B, Troung L, Rutledge M, Wheller T (1995) Somatic VHL mutation in clear cell papillary cystadenoma of the epididymis. Hum Pathol 26:1341-1346.
11. Glavac D, Dean M (1993) Optimization of the single-strand conformation polymorphism (SSCP) technique for the detection of point mutations. Hum Mutat 2:404-414.
12. Glenn GM, Daniel LN, Choyke P, Linehan WM, Oldfield E, Gorin MB, Hosoe S, Latif F, Weiss G, Walther M, Lerman MI, Zbar B (1991). von Hippel-Lindau disease: Distinct phenotypes suggest more than one mutant allele at the VHL locus. Hum Genet 87:207-210.
13. Gnarra J, Tory K, Weng Y, Schmidt L, Wei MW, Li H, Latif F, Liu S, Chen F, Suh F-M, Lubensky I, Duan D-SR, Florence C, Pozzati R, Walther MM, Bander NH, Grossman HB, Brauch H, Brooks JS, Isaacs WB, Lerman MI, Zbar B, Linehan WM (1994) VHL tumor suppressor gene mutations in renal carcinogenesis. Nature Genet 7:85-90.
14. Green J, Bowmer MI, Johnson GJ (1986) von Hippel-Lindau disease in a Newfoundland kindred. Can Med Assoc J 134:133-138.
15. Gross DJ, Avishai N, Meiner V, Zbar B, Abeliovich D (1996) Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene. J Clin Endo Metab (in press).
16. Hosoe S, Brauch H, Latif, F, Glenn G, Daniel, L, Bale S, Choyke P, Gorin M, Oldfield E, Bermna A, Goodman J, Orcutt ML, Hampsch K, Delisio J, Modi W, McBride W, Anglard P, Weiss G, Walther MM, Linehan WM, Lerman MI, Zbar B (1990) Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics 8:634-660.
17. Hultman T, Stahl S, Homes E, Uhlen M (1989) Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res 17:4937-4945.
18. Kanno H, Kondo L, Ito S, Yamamoto I, Fujii S, Torigoe T, Sakai N, Hosaka M, Shuin T, Yao M (1994) Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845-4847.
19. Karsdorp N, Elderson A, Wittebol-Post D, Hene RJ, Vos J, Feldberg MAM, van Gils APG, Jansen-Schillhorn van Veen JM, Vroom TM, Hoppener JWM, Lips JM (1994) von Hippel-Lindau disease: New strategies in early detection and treatment. Am J Med 97:158-168.
20. Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG Jr. (1995) Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. (1995) Science 269:1444-1446.
21. Kishida T, Stackhouse TM, Chen F, Lerman MI, Zbar B (1995) Cellular proteins that bind the von Hippel-Lindau disease gene product: Mapping of binding domains and the effect of missense mutations. Cancer Res 55:4544-4548.
22. Kishida T, Yao M, Chen F, Orcutt ML, Lerman MI, Zbar B (1994) A novel donor splice site mutation associated with two mRNAs in von Hippel-Lindau disease. Hum Mol Genet 3:1191-1192.
23. Knudson AG (1995) VHL gene mutation and clear-cell renal carcinoma. Cancer J Sci Am 1:180-181.
24. Lamiell JM, Salazar FG, Hsia YE (1989) von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore) 68:1-29.
25. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MW, Chen F. Glenn G, Choyke P, Walther MM, Weng Y, Duan D-SR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI (1993) Identification of the von Hippel-Lindau tumor suppressor gene. Science 260:1317-1320.
26. Linehan WM, Lerman MI, Zbar B (1995) Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA 273:564-570.
27. Maher ER, Yates JRW, Harries R, Benjamin C, Harris R, Ferguson-Smith MA (1990) QJ Med 77:1151-1163.
28. Melmon KL, Rosen SW (1964) Lindau's disease. Review of the literature and study of a single large kindred. Am J Med 36: 595-717.
29. Mulligan LM, Eng C, Attre T, Lyonnet S, Marsh DJ, AHyland VJ, Robinson BG, Frilling A, Verellen-Dumoulin C, Safar A, Verter DJ, Munnich A and Ponder BAJ (1994) Diverse phenotypes associated with exon 10 mutation of the RET protooncogene. Hum Mol Genet 3:2163-2167.
30. Neumann HPH (1987) Basic criteria for clinical diagnosis and genetic counseling in von Hippel-Lindau syndrome. J Vase Dis 16:220-226.
31. Neumann HPH and Wiestler OD (1991) Clustering of features of von Hippel-Lindau disease: Evidence of a complex genetic locus. Lancet 337:1052-1054.
32. Neumann HPH, Berger DP, Sigmund G, Blum S, Schmidt D, Farmer RJ, Volk B et al. (1993) Pheochromocytomas, multiple endocrine neoplasia type 2 and von Hippel-Lindau disease. N Engl J Med 329:1531-1538.
33. Neumann HPH, Eng C, Mulligan LM, Glavac D, Zauner I, Ponder BAJ, Crossey P, Maher ER, Brauch H. (1995) Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II. JAMA 274:1149-1151.
34. Orita M, Iwahara H, Kanazawa H, Kiyaksi K, Sekiya T (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Nat Acad Sci USA 86:2766-2770.
35. Richard S, Beigelman C, Duclos JM, Fendler JP, Plauchu H, Plouin PF, Resche F, Schlumberger M, Vermesse B, Proye C (1994) Pheochromocytoma as the first manifestation of von Hippel-Lindau disease. Surgery 116:1076-1081.
36. Richards FM, Payne SJ, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER. (1995) Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet 4:2139-2143.
37. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocclardi R, Lerone M, Kaariainen H, Martucciello G (1994) Point mutations affecting the RET oncogene in Hirschsprung's Disease. Nature 367:377-378.
38. Schmidt L, Li F, Brown RS. Berg S, Chen F, Wei M-W, Tory K. Lerman MI, Zbar B (1995) Mechanisms of tumorigenesis of renal carcinomas associated with the constitutional 3;8 translocation. Cancer J Sci Am 1:191-195.
39. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852-2855.
40. Tisherman SE, Gregg FJ, Danowskt TS (1962) Familial pheochromocytoma. JAMA 182:152-156.
41. Tisherman SE, Tisherman BG, Tisherman SA, Dunmire S, Levey OS, Mulvihill J (1993) Three decade investigation of familial pheochromocytoma. An allele of von Hippel-Lindau disease? Arch Int Med 153:2550-2556.
42. Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins JS, Neumann HPH, Laidlaw J, Li FP, Klein-Szanto AJP, Seizinger BR, Kley N (1994) Germ-line mutations in the von Hippel-Lindau tumor suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55:1092-1102.
43. Zbar B (1995) von Hippel-Lindau disease and sporadic renal cell carcinoma. Cancer Surveys 25:219-232.